Biblio

Found 5 results

Filters: Author is Goldstein, Theodore C [Clear All Filters]

2014

A. Bivol, Baertsch, R., Sokolov, A., Paull, E., Newton, Y., Goldstein, T. C., Foye, A., Pourmand, N., Youngren, J., Parulkar, R., and , “Pathway-based signature analysis of RNA-seq data to reveal new targetable avenues for metastatic castration-resistant prostate cancer (mCRPC) patients (pts): Preliminary results from the SU2C/PCF/AACR West Coast Prostate Cancer Dream Team (WCDT).”. American Society of Clinical Oncology, 2014.

2013

P. G. Febbo, Goldstein, T. C., Baertsch, R., Youngren, J., Newton, Y., Bivol, A., Small, E. Jay, and Stuart, J. M., “Identification of polo-like kinase 1 (PLK1) in aggressive prostate cancer by paradigm analysis.”. American Society of Clinical Oncology, 2013.

2012

L. M. Heiser, Sadanandam, A., Kuo, W. - L., Benz, S. C., Goldstein, T. C., Ng, S., Gibb, W. J., Wang, N. J., Ziyad, S., Tong, F., and , “Subtype and pathway specific responses to anticancer compounds in breast cancer”, Proceedings of the National Academy of Sciences, vol. 109, pp. 2724–2729, 2012.

M. James Ellis, Ding, L., Shen, D., Luo, J., Suman, V. J., Goiffon, R. J., Wallis, J. W., Goldstein, T. C., Chen, K., Allred, D. Craig, and , “Whole genome sequencing to characterize luminal-type breast cancer.”. American Society of Clinical Oncology, 2012.

M. J. Ellis, Ding, L., Shen, D., Luo, J., Suman, V. J., Wallis, J. W., Van Tine, B. A., Hoog, J., Goiffon, R. J., Goldstein, T. C., and , “Whole-genome analysis informs breast cancer response to aromatase inhibition”, Nature, vol. 486, p. 353, 2012.